This webinar will be hosted readily available and live on-demandTuesday, September 20, 2022 11:00 AM – 12:00 PM Eastern TimeAntibodies directed versus the SARS-CoV-2 spike protein receptor binding domain (RBD) show potent neutralizing activity. Researchers have recognized numerous classes of these antibodies in COVID-19 patients that are mostly accountable for the protective immunity caused by the present vaccines. Hence, there is an ongoing need to precisely figure out the amount and duration of the antibody reaction against the SARS-CoV-2 spike RBD.In this LabTools webinar brought to you by Sartorius, Julie Lovchik will present a freshly established and validated package that supplies a quick, robust, and sensitive serological assay that at the same time determines IgG, iga, and igm anti-SARS-CoV-2 spike RBD antibodies in human serum and plasma samples.Topics to be coveredCombining innovative flow cytometry instrumentation with the SARS-CoV-2 antibody detection kitThe benefits of examining significant immunological isotypes in a single assayCharacteristic antibody kinetics in reaction to COVID-19 infection and vaccinationJulie Lovchik, PhDScientistSartoriusSponsored by
